Detection of Gene Fusions and Rearrangements in Formalin-Fixed, Paraffin-Embedded Solid Tumor Specimens Using

Kristyn Galbraith1, Jamin Wu1, Kristin Sikkink2

  • 1Department of Pathology, NYU Langone Health, and NYU Grossman School of Medicine, New York, New York.

Insights

High-throughput chromosome conformation capture (Hi-C) accurately detects cancer-driving chromosomal structural variants (SVs) in FFPE tissues. This DNA-based method surpasses RNA-based approaches, revealing novel SVs and actionable biomarkers.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Diagnostics

Background:

  • Chromosomal structural variants (SVs) are key drivers of cancer development.
  • Existing SV detection methods have limitations, including low throughput and reliance on RNA, which is degraded in FFPE samples and cannot detect non-fusion SVs.

Purpose of the Study:

  • To evaluate the efficacy of high-throughput chromosome conformation capture (Hi-C) for genome-wide SV analysis in formalin-fixed, paraffin-embedded (FFPE) tumor tissues.
  • To compare Hi-C performance against established clinical methods like FISH and RNA NGS.
  • To identify novel SVs and potential therapeutic targets in FFPE samples.

Main Methods:

  • Retrospective analysis of 71 FFPE specimens from 10 solid tumor types using Hi-C, a DNA-based next-generation sequencing (NGS) method.
  • Comparison of Hi-C results with clinical FISH and RNA NGS data.
  • Analysis of SV formation mechanisms and clinical actionability.

Main Results:

  • Hi-C demonstrated high concordance (98%) with clinical FISH and RNA NGS for known SV detection.
  • Hi-C identified SV formation mechanisms (e.g., chromothripsis, extrachromosomal DNA) and intergenic rearrangements missed by RNA NGS.
  • SV drivers were detected in 71% of cases where prior clinical methods failed, with 14% being clinically actionable and another 14% involving targetable biomarkers.

Conclusions:

  • Hi-C is a robust and accurate method for comprehensive SV analysis in FFPE tissues.
  • Hi-C can uncover previously undetected SVs and mechanisms of cancer development.
  • Hi-C has the potential to be integrated into clinical NGS workflows for improved cancer diagnostics and treatment strategies.